Skip to content

Clinical Performance of Stenfilcon A Versus Filcon II 3

Clinical Performance of Stenfilcon A Versus Filcon II 3

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01808209
Enrollment
60
Registered
2013-03-11
Start date
2013-01-31
Completion date
2013-05-31
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

Clinical Performance of Stenfilcon vs. Filcon II 3

Detailed description

The objective of this study is to compare the comfort and clinical performance of Stenfilcon vs. Filcon II 3 compared to subject's habitual contact lenses. The null hypothesis is that there is no difference in the clinical performance between the two sets of lenses.

Interventions

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subjects must satisfy the following conditions prior to inclusion in the study: * Based on his/her knowledge, must be in good general health. Be of legal age (18 years) or older. * Be able and willing to adhere to the instructions set forth in this protocol and complete all specified evaluation. * Read, indicate understanding of, and sign Written Informed Consent (Appendix 1) * Require a contact lens prescription between -0.50 and -6.00 and have no more than -.75dioptor (D) of astigmatism in both eyes * Achieve visual acuity of 6/9 or better in each eye with a spherical contact lens prescription. * An existing soft contact lens wearer of any modality. * Must be able to wear their lenses at least 6 full days over the 7 days; 14 hours per day, assuming there are no contraindications for doing so. * Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having: * No amblyopia. * No evidence of lid abnormality or infection (e.g. entropion, ectropion, chalazia, recurrent styes). * No clinically significant slit lamp findings (e.g. infiltrates or other slit lamp findings greater than Grade 2: corneal edema, tarsal abnormalities, and conjunctival injection). * No other active ocular disease (e.g. glaucoma, history of recurrent corneal erosions, cornea \[infiltrates\], conjunctiva, lids, and intraocular infection or inflammation of an allergic, bacterial, or viral etiology.) * No aphakia

Exclusion criteria

Any of the following will render a subject ineligible for inclusion: * Neophytes, who have not worn lenses before * Greater than 0.75D of refractive astigmatism in either eye * Presence of clinically significant (grade 3 or above) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures. * Presence of ocular or systemic disease or need of medication which might interfere with contact lens wear. * Slit lamp findings that would contraindicate contact lens wear such as: * Pathological dry eye or associated findings * Pterygium, pinguecula or corneal scars within the visual axis * Neovascularization \> 0.75 mm in from the limbus * Giant papillary conjunctivitis (GPC) Grade 3 or above * Anterior uveitis or iritis (past or present) * Seborrheic eczema, seborrheic conjunctivitis * History of corneal ulcer or fungal infections * Poor personal hygiene * A known history of corneal hypoesthesia (reduced corneal sensitivity). * Contact lens best corrected Snellen visual acuities (VA) worse than 6/9 * Aphakia, Keratoconus or a highly irregular cornea

Design outcomes

Primary

MeasureTime frameDescription
Wettability1 WeekParticipant rating for surface wettability. Collected at 1 week. Tear film analysis in seconds.
Vision QualityBaselineParticipant rating of vision quality. Collected at baseline for habitual lens. (0-100; 0=extremely poor vision totally blurred 100=excellent vision totally sharp)
Eye WhitenessBaselineParticipant rating for eye whiteness. Collected at baseline for habitual lenses. (0-100, 0= total redness and 100= totally white).
Overall SatisfactionBaselineParticipant rating for overall satisfaction. Collected at baseline for habitual lenses. (0-100, 0= extremely dissatisfied and 100= extremely satisfied).
Visual Acuity logMARBaselineAssessment of Monocular (MHCVA) Right eye (OD), left eye (OS) and Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at baseline for habitual lens. logMAR.
Daily and Comfortable Wearing TimeBaselineParticipant rating of lens Daily and Comfortable Wearing Time. Collected at baseline for all habitual lenses.(The hours of average comfortable wearing time and average daily wearing time.)
Handling1 WeekParticipant rating for lens handling. Collected at 1 week. (Insertion: 0-100, 0= could not get it in and 100= went in without a problem. Removal: 0= could not get it out and 100= came out without a problem. Blister: 0=impossible and 100=came out extremely easily).
ComfortBaselineParticipant rating of lens comfort. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable,100=extreme comfort / cannot feel them at all)
DrynessBaselineParticipant rating of lens dryness. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable, 100=extreme comfort/ cannot feel them at all)

Secondary

MeasureTime frameDescription
Conjunctival RednessBaselineAssessment of ocular health. Collected at baseline after removal of lenses. Percentage of conjunctival redness.
Corneal StainingBaselineAssessment of ocular health. Collected at baseline after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )
Conjunctival Staining1 WeekAssessment of ocular health. Collected at 1 week after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )
Blood Vessel CoverageBaselineAssessment of ocular health. Collected at baseline after removal of lenses. Percent of blood vessel coverage.

Countries

United Kingdom

Participant flow

Recruitment details

Sixty habitual contact lens wearing subjects were recruited by the Optometry Clinic at Aston University

Pre-assignment details

All subjects were habitual lens wearers and were randomized to each pair of study lenses. Only one patient failed to complete all study visits and their data was excluded from the analysis.

Participants by arm

ArmCount
Stenfilcon A Then Filcon II 3
All participants completing the study were habitual lens wearers. All participants wore both sets of study lenses. Participants were randomized to wear either pair of study lenses as a first pair and then crossed over to wear the alternate second pair of study lenses. Each worn one week.
33
Filcon II 3 Then Stenfilcon A
All participants completing the study were habitual lens wearers. All participants wore both sets of study lenses. Participants were randomized to wear either pair of study lenses as a first pair and then crossed over to wear the alternate second pair of study lenses. Each worn one week.
26
Total59

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up01

Baseline characteristics

CharacteristicFilcon II 3 Then Stenfilcon ATotalStenfilcon A Then Filcon II 3
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
26 Participants59 Participants33 Participants
Region of Enrollment
United Kingdom
26 participants59 participants33 participants
Sex: Female, Male
Female
18 Participants42 Participants24 Participants
Sex: Female, Male
Male
8 Participants17 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 600 / 60
serious
Total, serious adverse events
0 / 600 / 60

Outcome results

Primary

Comfort

Participant rating for comfort. Collected at 1 week. (0-100, 0= very uncomfortable and 100= extreme comfort/cannot feel them at all).

Time frame: 1 Week

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupComfortInsertion93.0 units on a scaleStandard Deviation 9.6
Overall Study GroupComfortAfter 4 hours89.7 units on a scaleStandard Deviation 14.6
Overall Study GroupComfortAfter 8 hours81.7 units on a scaleStandard Deviation 17.7
Overall Study GroupComfortRemoval75.8 units on a scaleStandard Deviation 18.8
Filcon II 3ComfortRemoval72.4 units on a scaleStandard Deviation 20
Filcon II 3ComfortInsertion90.6 units on a scaleStandard Deviation 13.2
Filcon II 3ComfortAfter 8 hours79.0 units on a scaleStandard Deviation 17.6
Filcon II 3ComfortAfter 4 hours88.8 units on a scaleStandard Deviation 11.8
Primary

Comfort

Participant rating of lens comfort. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable,100=extreme comfort / cannot feel them at all)

Time frame: Baseline

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupComfortOn Insertion85.0 units on a scaleStandard Deviation 17
Overall Study GroupComfortAfter 4 Hours91.8 units on a scaleStandard Deviation 9.1
Overall Study GroupComfortAfter 8 Hours80.8 units on a scaleStandard Deviation 15.7
Overall Study GroupComfortOn Removal75.3 units on a scaleStandard Deviation 19.7
Primary

Daily and Comfortable Wearing Time

Participant rating of lens Daily and Comfortable Wearing Time. Collected at baseline for all habitual lenses.(The hours of average comfortable wearing time and average daily wearing time.)

Time frame: Baseline

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupDaily and Comfortable Wearing TimeAverage Wearing Time9.8 hoursStandard Deviation 3.1
Overall Study GroupDaily and Comfortable Wearing TimeAverage Comfortable Wearing Time7.7 hoursStandard Deviation 3.4
Primary

Daily and Comfortable Wearing Time

Participant rating of lens Daily and Comfortable Wearing Time. Collected at 1 week wear for each lens.(The hours of average comfortable wearing time and average daily wearing time.)

Time frame: 1 week

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupDaily and Comfortable Wearing TimeAverage Wearing Time11.4 hoursStandard Deviation 2.6
Overall Study GroupDaily and Comfortable Wearing TimeAverage Comfortable Wearing Time8.7 hoursStandard Deviation 3
Filcon II 3Daily and Comfortable Wearing TimeAverage Wearing Time10.8 hoursStandard Deviation 2.6
Filcon II 3Daily and Comfortable Wearing TimeAverage Comfortable Wearing Time8.7 hoursStandard Deviation 2.8
Primary

Dryness

Participant rating for dryness. Collected at 1 week. (0-100, 0= very uncomfortable and 100= extreme comfort/cannot feel them at all).

Time frame: 1 Week

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupDrynessInsertion94.4 units on a scaleStandard Deviation 11.8
Overall Study GroupDrynessAfter 4 hours88.9 units on a scaleStandard Deviation 13.3
Overall Study GroupDrynessAfter 8 hours78.5 units on a scaleStandard Deviation 19
Overall Study GroupDrynessRemoval72.9 units on a scaleStandard Deviation 21.1
Filcon II 3DrynessRemoval70.8 units on a scaleStandard Deviation 19.1
Filcon II 3DrynessInsertion93.6 units on a scaleStandard Deviation 11.6
Filcon II 3DrynessAfter 8 hours79.2 units on a scaleStandard Deviation 16.7
Filcon II 3DrynessAfter 4 hours88.0 units on a scaleStandard Deviation 12.4
Primary

Dryness

Participant rating of lens dryness. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable, 100=extreme comfort/ cannot feel them at all)

Time frame: Baseline

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupDrynessOn Insertion85.6 units on a scaleStandard Deviation 26.8
Overall Study GroupDrynessAfter 4 Hours84.0 units on a scaleStandard Deviation 21.7
Overall Study GroupDrynessAfter 8 Hours73.8 units on a scaleStandard Deviation 22
Overall Study GroupDrynessOn Removal67.1 units on a scaleStandard Deviation 25.3
Primary

Eye Whiteness

Participant rating for eye whiteness. Collected at baseline for habitual lenses. (0-100, 0= total redness and 100= totally white).

Time frame: 1 Week

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupEye Whiteness85.3 units on a scaleStandard Deviation 12.5
Filcon II 3Eye Whiteness84.9 units on a scaleStandard Deviation 13.5
Primary

Eye Whiteness

Participant rating for eye whiteness. Collected at baseline for habitual lenses. (0-100, 0= total redness and 100= totally white).

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupEye Whiteness82.5 units on a scaleStandard Deviation 15
Primary

Handling

Participant rating for lens handling. Collected at 1 week. (Insertion: 0-100, 0= could not get it in and 100= went in without a problem. Removal: 0= could not get it out and 100= came out without a problem. Blister: 0=impossible and 100=came out extremely easily).

Time frame: 1 Week

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupHandlingFrom Blister90.8 units on a scaleStandard Deviation 11.7
Overall Study GroupHandlingInside Out84.9 units on a scaleStandard Deviation 24.6
Overall Study GroupHandlingInsertion93.4 units on a scaleStandard Deviation 10.7
Overall Study GroupHandlingRemoval90.0 units on a scaleStandard Deviation 13.6
Filcon II 3HandlingRemoval92.0 units on a scaleStandard Deviation 11.3
Filcon II 3HandlingFrom Blister92.2 units on a scaleStandard Deviation 0.32
Filcon II 3HandlingInsertion89.3 units on a scaleStandard Deviation 13
Filcon II 3HandlingInside Out86.4 units on a scaleStandard Deviation 25.9
Primary

Overall Satisfaction

Participant rating for overall satisfaction. Collected at 1 week for study lenses. (0-100, 0= extremely dissatisfied and 100= extremely satisfied).

Time frame: 1 Week

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupOverall Satisfaction85.7 units on a scaleStandard Deviation 12.4
Filcon II 3Overall Satisfaction82.5 units on a scaleStandard Deviation 16.1
Primary

Overall Satisfaction

Participant rating for overall satisfaction. Collected at baseline for habitual lenses. (0-100, 0= extremely dissatisfied and 100= extremely satisfied).

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupOverall Satisfaction88.1 units on a scaleStandard Deviation 14
Primary

Vision Quality

Participant rating of vision quality. Collected at baseline for habitual lens. (0-100; 0=extremely poor vision totally blurred 100=excellent vision totally sharp)

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupVision Quality92.2 units on a scaleStandard Deviation 8.6
Primary

Vision Quality

Participant rating of vision quality. Collected at 1 week. (0-100; 0=extremely poor vision totally blurred 100=excellent vision totally sharp)

Time frame: 1 Week

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupVision Quality89.9 units on a scaleStandard Deviation 11.2
Filcon II 3Vision Quality89.0 units on a scaleStandard Deviation 11.7
Primary

Visual Acuity logMAR

Assessment of Monocular (MHCVA) Right eye (OD), left eye (OS) and Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at baseline for habitual lens. logMAR.

Time frame: Baseline

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupVisual Acuity logMARMHCVA OS-0.01 logMARStandard Deviation 0.08
Overall Study GroupVisual Acuity logMARBHCVA-0.05 logMARStandard Deviation 0.07
Overall Study GroupVisual Acuity logMARMHCVA OD-0.01 logMARStandard Deviation 0.08
Primary

Visual Acuity logMAR

Assessment of Monocular (MHCVA) Right eye (OD), left eye (OS) and Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at dispense for study lenses. logMAR.

Time frame: Dispense

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupVisual Acuity logMARMHCVA OD-0.09 logMARStandard Deviation 0.1
Overall Study GroupVisual Acuity logMARMHCVA OS-0.09 logMARStandard Deviation 0.08
Overall Study GroupVisual Acuity logMARBHCVA-0.12 logMARStandard Deviation 0.08
Filcon II 3Visual Acuity logMARMHCVA OD-0.07 logMARStandard Deviation 0.07
Filcon II 3Visual Acuity logMARMHCVA OS-0.07 logMARStandard Deviation 0.06
Filcon II 3Visual Acuity logMARBHCVA-0.11 logMARStandard Deviation 0.07
Primary

Visual Acuity logMAR

Assessment of Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at 1 week for study lenses. logMAR

Time frame: 1 Week

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupVisual Acuity logMAR-0.06 logMARStandard Deviation 0.06
Filcon II 3Visual Acuity logMAR-0.03 logMARStandard Deviation 0.07
Primary

Wettability

Participant rating for surface wettability. Collected at 1 week. Tear film analysis in seconds.

Time frame: 1 Week

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupWettabilityRight Eye10.9 secondsStandard Deviation 6.5
Overall Study GroupWettabilityLeft Eye11.6 secondsStandard Deviation 9
Filcon II 3WettabilityRight Eye9.2 secondsStandard Deviation 5.4
Filcon II 3WettabilityLeft Eye9.6 secondsStandard Deviation 6.1
Secondary

Blood Vessel Coverage

Assessment of ocular health. Collected at baseline after removal of lenses. Percent of blood vessel coverage.

Time frame: Baseline

Population: Prior to randomization

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupBlood Vessel CoverageRight Eye3.68 percentage of blood vessel coverageStandard Deviation 3.05
Overall Study GroupBlood Vessel CoverageLeft Eye3.74 percentage of blood vessel coverageStandard Deviation 2.74
Secondary

Blood Vessel Coverage

Assessment of ocular health. Collected at 1 week after removal of lenses. Percentage of blood vessel coverage.

Time frame: 1 Week

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupBlood Vessel CoverageRight Eye4.63 percentage of blood vessel coverageStandard Deviation 2.9
Overall Study GroupBlood Vessel CoverageLeft Eye5.00 percentage of blood vessel coverageStandard Deviation 3.32
Filcon II 3Blood Vessel CoverageRight Eye4.41 percentage of blood vessel coverageStandard Deviation 2.94
Filcon II 3Blood Vessel CoverageLeft Eye5.25 percentage of blood vessel coverageStandard Deviation 4.42
Secondary

Conjunctival Redness

Assessment of ocular health. Collected at 1 week after removal of lenses. Percentage of conjunctival redness.

Time frame: 1 Week

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupConjunctival RednessRight Eye35.6 percentage of rednessStandard Deviation 1.4
Overall Study GroupConjunctival RednessLeft Eye35.8 percentage of rednessStandard Deviation 1.4
Filcon II 3Conjunctival RednessRight Eye35.4 percentage of rednessStandard Deviation 1.3
Filcon II 3Conjunctival RednessLeft Eye35.4 percentage of rednessStandard Deviation 1.3
Secondary

Conjunctival Redness

Assessment of ocular health. Collected at baseline after removal of lenses. Percentage of conjunctival redness.

Time frame: Baseline

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupConjunctival RednessRight Eye35.1 percentage of rednessStandard Deviation 1
Overall Study GroupConjunctival RednessLeft Eye35.2 percentage of rednessStandard Deviation 1.2
Secondary

Conjunctival Staining

Assessment of ocular health. Collected at 1 week after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )

Time frame: 1 Week

Population: All 59 subjects were habitual lens wearers and randomized to both sets of study lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupConjunctival Staining0.6 units on a scaleStandard Deviation 0.5
Filcon II 3Conjunctival Staining0.6 units on a scaleStandard Deviation 0.4
Secondary

Corneal Staining

Assessment of ocular health. Collected at baseline after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )

Time frame: Baseline

Population: Prior to randomization

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupCorneal Staining0.6 units on a scaleStandard Deviation 0.6
Secondary

Corneal Staining

Assessment of ocular health. Collected at 1 week after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )

Time frame: 1 Week

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupCorneal Staining0.4 units on a scaleStandard Deviation 0.4
Filcon II 3Corneal Staining0.5 units on a scaleStandard Deviation 0.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026